Cite
HARVARD Citation
Magro, F. et al. (2019). Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab. Therapeutic advances in gastroenterology. p. . [Online].